CarisbaMate-d4 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Labelled Carisbamate; it is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models.

CarisbaMate-d4 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CarisbaMate-d4 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8617865335152	Mandy@hangyubiotech.com	China	10986	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44806	58
Shandong Mopai Biotechnology Co., Ltd	13070690626	admin@mopaikeji.com	China	10757	58
	58896805	7993601name@qq.com	CHINA	15620	58

---

• CarisbaMate-d4
• [2H4]-Carisbamate
• 1292841-50-9